Question-based Drug Development for psilocybin - Authors' reply.
Lancet Psychiatry – September 01, 2016
Source: PubMed
Summary
Psilocybin's therapeutic promise requires a unique development strategy. Standard drug development frameworks are often inadequate for such distinct compounds. A proposed question-based method systematically guides research by addressing specific inquiries at each phase. This approach effectively minimizes risks, streamlines clinical trials, and ensures robust data, responsibly advancing psychedelic therapies.
Abstract
Question-based Drug Development for psilocybin - Authors' reply.